Nugenerex Immuno-OncologyNUGX
13F holders, Q2 2025 (June 30)1holders
0new positions
0sold out
$0.00avg. 13F price*
At the end of Q2 2025, 1 institutions reported holding Nugenerex Immuno-Oncology Inc. (NUGX) in their 13F filings, unchanged from Q1 2025. 0 opened new positions and 0 sold out. The largest holder was NBT Bank, N.A. ($0).
- Company
- Nugenerex Immuno-Oncology Inc.
- CUSIP
- 67053X102
- Latest filing quarter
- Q1 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
Ownership 1 holders
| NBT Bank, N.A. | 0.00% | No change | 42 | $0 |
"% of holder's portfolio" is NUGX's weight in each manager's 13F, not the share of Nugenerex Immuno-Oncology Inc. the manager owns.